FDA 483 - Vimta Labs, Limited

An FDA inspection of Vimta Labs Limited, a Contract Research Organization in Hyderabad, India, conducted in April 2018, identified one observation. The inspection revealed issues with chromatographic peak resolution, where an interfering peak was not fully separated from the analyte peak in specific study runs. This indicates a potential concern with analytical method performance or data integrity.